Flonase Nasal Spray
Company: GlaxoSmithKlineApproval Status: Approved November 1997
Treatment for: allergic rhinitis
Areas: Immune System; Respiratory
General Information
Flonase Nasal Spray has been approved by the FDA for the treatment of seasonal and perennial allergic rhintis in children four years and older. This supplementary new dosage application represents an extension of the product to include younger children.
Flonase Nasal Spray Drug Information
The Flonase Nasal Spray drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
